Granules India completes stake sale in Granules-Biocause Pharmaceutical

04 Feb 2020 Evaluate

Granules India has completed transaction of stake sale in Granules-Biocause Pharmaceutical, pursuant to which Granules-Biocause Pharmaceutical ceased to be the Joint Venture of the company. Earlier, the company had entered into an agreement with Hubei Biocause Heilen Pharmaceutical Co., Joint Venture Partner for sale of 33,000,000 equity shares of 1 RMB each fully paid-up held by the Company in Granules-Biocause Pharmaceutical for a consideration of RMB 109 million.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).


Granules India Share Price

601.50 -4.40 (-0.73%)
10-Jan-2025 09:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1819.25
Dr. Reddys Lab 1381.80
Cipla 1492.95
Lupin 2249.00
Zydus Lifesciences 1012.15
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.